1 Burge, F. & Kockelbergh, R. Closing the Gender Gap: Can We Improve Bladder Cancer Survival in Women? - A Systematic Review of Diagnosis, Treatment and Outcomes. Urol Int 97, 373-379, doi:10.1159/000449256 (2016).
2 Dobruch, J. et al. Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. Eur Urol 69, 300-310, doi:10.1016/j.eururo.2015.08.037 (2016).
3 Thorstenson, A. et al. Gender-related differences in urothelial carcinoma of the bladder: a population-based study from the Swedish National Registry of Urinary Bladder Cancer. Scand J Urol 50, 292-297, doi:10.3109/21681805.2016.1158207 (2016).
4 Antoni, S. et al. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. Eur Urol 71, 96-108, doi:10.1016/j.eururo.2016.06.010 (2017).
5 Kamat, A. M. et al. Bladder cancer. Lancet 388, 2796-2810, doi:10.1016/S0140-6736(16)30512-8 (2016).
6 Sanli, O. et al. Bladder cancer. Nat Rev Dis Primers 3, 17022, doi:10.1038/nrdp.2017.22 (2017).
7 Soloway, M. S. Bladder cancer: Lack of progress in bladder cancer--what are the obstacles? Nat Rev Urol 10, 5-6, doi:10.1038/nrurol.2012.219 (2013).
8 Yu, F. X., Zhao, B. & Guan, K. L. Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer. Cell 163, 811-828, doi:10.1016/j.cell.2015.10.044 (2015).
9 Maugeri-Sacca, M. & De Maria, R. The Hippo pathway in normal development and cancer. Pharmacol Ther 186, 60-72, doi:10.1016/j.pharmthera.2017.12.011 (2018).
10 Zheng, X. et al. LncRNA wires up Hippo and Hedgehog signaling to reprogramme glucose metabolism. Embo j 36, 3325-3335, doi:10.15252/embj.201797609 (2017).
11 Cox, A. G. et al. Yap regulates glucose utilization and sustains nucleotide synthesis to enable organ growth. Embo j 37, doi:10.15252/embj.2018100294 (2018).
12 Koo, J. H. & Guan, K. L. Interplay between YAP/TAZ and Metabolism. Cell Metab 28, 196-206, doi:10.1016/j.cmet.2018.07.010 (2018).
13 Zhang, X. et al. The role of YAP/TAZ activity in cancer metabolic reprogramming. Mol Cancer 17, 134, doi:10.1186/s12943-018-0882-1 (2018).
14 Meng, Z., Moroishi, T. & Guan, K. L. Mechanisms of Hippo pathway regulation. Genes Dev 30, 1-17, doi:10.1101/gad.274027.115 (2016).
15 Zhao, B., Li, L., Lei, Q. & Guan, K. L. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev 24, 862-874, doi:10.1101/gad.1909210 (2010).
16 Lin, K. C. et al. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation. Nat Cell Biol 19, 996-1002, doi:10.1038/ncb3581 (2017).
17 Lin, K. C., Park, H. W. & Guan, K. L. Regulation of the Hippo Pathway Transcription Factor TEAD. Trends Biochem Sci 42, 862-872, doi:10.1016/j.tibs.2017.09.003 (2017).
18 De Craene, B. & Berx, G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 13, 97-110, doi:10.1038/nrc3447 (2013).
19 Diepenbruck, M. & Christofori, G. Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe? Curr Opin Cell Biol 43, 7-13, doi:10.1016/j.ceb.2016.06.002 (2016).
20 Pastushenko, I. & Blanpain, C. EMT Transition States during Tumor Progression and Metastasis. Trends Cell Biol 29, 212-226, doi:10.1016/j.tcb.2018.12.001 (2019).
21 Lemasters, J. J. The mitochondrial permeability transition: from biochemical curiosity to pathophysiological mechanism. Gastroenterology 115, 783-786 (1998).
22 Singh, M., Yelle, N., Venugopal, C. & Singh, S. K. EMT: Mechanisms and therapeutic implications. Pharmacol Ther 182, 80-94, doi:10.1016/j.pharmthera.2017.08.009 (2018).
23 Xu, Z. et al. Sodium Butyrate Inhibits Colorectal Cancer Cell Migration by Downregulating Bmi-1 Through Enhanced miR-200c Expression. Mol Nutr Food Res 62, e1700844, doi:10.1002/mnfr.201700844 (2018).
24 Wang, F. et al. Sodium butyrate inhibits migration and induces AMPK-mTOR pathway-dependent autophagy and ROS-mediated apoptosis via the miR-139-5p/Bmi-1 axis in human bladder cancer cells. FASEB J, doi:10.1096/fj.201902626R (2020).
25 Han, L. L., Yin, X. R. & Zhang, S. Q. miR-103 promotes the metastasis and EMT of hepatocellular carcinoma by directly inhibiting LATS2. Int J Oncol 53, 2433-2444, doi:10.3892/ijo.2018.4580 (2018).
26 Hu, Y. et al. miR-665 promotes hepatocellular carcinoma cell migration, invasion, and proliferation by decreasing Hippo signaling through targeting PTPRB. Cell Death Dis 9, 954, doi:10.1038/s41419-018-0978-y (2018).
27 Yao, P. et al. ANKHD1 silencing suppresses the proliferation, migration and invasion of CRC cells by inhibiting YAP1-induced activation of EMT. Am J Cancer Res 8, 2311-2324 (2018).
28 Braitsch, C. M. et al. LATS1/2 suppress NFkappaB and aberrant EMT initiation to permit pancreatic progenitor differentiation. PLoS Biol 17, e3000382, doi:10.1371/journal.pbio.3000382 (2019).
29 Karvonen, H., Barker, H., Kaleva, L., Niininen, W. & Ungureanu, D. Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways. Cells 8, doi:10.3390/cells8080812 (2019).
30 Carthew, R. W. & Sontheimer, E. J. Origins and Mechanisms of miRNAs and siRNAs. Cell 136, 642-655, doi:10.1016/j.cell.2009.01.035 (2009).
31 Kloosterman, W. P. & Plasterk, R. H. The diverse functions of microRNAs in animal development and disease. Dev Cell 11, 441-450, doi:10.1016/j.devcel.2006.09.009 (2006).
32 Trang, P., Weidhaas, J. B. & Slack, F. J. MicroRNAs as potential cancer therapeutics. Oncogene 27 Suppl 2, S52-57, doi:10.1038/onc.2009.353 (2008).
33 Chen, Z. et al. miR-190b promotes tumor growth and metastasis via suppressing NLRC3 in bladder carcinoma. FASEB J, doi:10.1096/fj.201901764R (2020).
34 Jin, H. et al. Oncogenic role of MIR516A in human bladder cancer was mediated by its attenuating PHLPP2 expression and BECN1-dependent autophagy. Autophagy, 1-15, doi:10.1080/15548627.2020.1733262 (2020).
35 Del Sal, G., Ruaro, M. E., Philipson, L. & Schneider, C. The growth arrest-specific gene, gas1, is involved in growth suppression. Cell 70, 595-607, doi:10.1016/0092-8674(92)90429-g (1992).
36 Ma, Y., Qin, H. & Cui, Y. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway. Biochem Biophys Res Commun 441, 958-963, doi:10.1016/j.bbrc.2013.11.010 (2013).
37 Mo, H. et al. WT1 is involved in the Akt-JNK pathway dependent autophagy through directly regulating Gas1 expression in human osteosarcoma cells. Biochem Biophys Res Commun 478, 74-80, doi:10.1016/j.bbrc.2016.07.090 (2016).
38 Gao, L., Wang, S., Meng, J. & Sun, Y. LncRNA LUADT1 Promotes Oral Squamous Cell Carcinoma Cell Proliferation by Regulating miR-34a/GAS1 Axis. Cancer Manag Res 12, 3401-3407, doi:10.2147/cmar.S238830 (2020).
39 Sarkar, S. et al. Microglia induces Gas1 expression in human brain tumor-initiating cells to reduce tumorigenecity. Sci Rep 8, 15286, doi:10.1038/s41598-018-33306-0 (2018).
40 Conceicao, A. L. et al. Downregulation of OCLN and GAS1 in clear cell renal cell carcinoma. Oncol Rep 37, 1487-1496, doi:10.3892/or.2017.5414 (2017).
41 Li, Q. et al. Gas1 Inhibits Metastatic and Metabolic Phenotypes in Colorectal Carcinoma. Mol Cancer Res 14, 830-840, doi:10.1158/1541-7786.MCR-16-0032 (2016).
42 Yang, D. et al. MiR-942 mediates hepatitis C virus-induced apoptosis via regulation of ISG12a. PLoS One 9, e94501, doi:10.1371/journal.pone.0094501 (2014).
43 Xu, C. Y., Dong, J. F., Chen, Z. Q., Ding, G. S. & Fu, Z. R. MiR-942-3p Promotes the Proliferation and Invasion of Hepatocellular Carcinoma Cells by Targeting MBL2. Cancer Control 26, 1073274819846593, doi:10.1177/1073274819846593 (2019).
44 Holden, J. K. & Cunningham, C. N. Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors. Cancers (Basel) 10, doi:10.3390/cancers10030081 (2018).
45 Sanchez-Hernandez, L., Hernandez-Soto, J., Vergara, P., Gonzalez, R. O. & Segovia, J. Additive effects of the combined expression of soluble forms of GAS1 and PTEN inhibiting glioblastoma growth. Gene Ther 25, 439-449, doi:10.1038/s41434-018-0020-0 (2018).
46 Hansen, C. G., Moroishi, T. & Guan, K. L. YAP and TAZ: a nexus for Hippo signaling and beyond. Trends Cell Biol 25, 499-513, doi:10.1016/j.tcb.2015.05.002 (2015).
47 Moya, I. M. & Halder, G. Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine. Nat Rev Mol Cell Biol 20, 211-226, doi:10.1038/s41580-018-0086-y (2019).
48 Moroishi, T., Hansen, C. G. & Guan, K. L. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer 15, 73-79, doi:10.1038/nrc3876 (2015).
49 Zanconato, F., Cordenonsi, M. & Piccolo, S. YAP/TAZ at the Roots of Cancer. Cancer Cell 29, 783-803, doi:10.1016/j.ccell.2016.05.005 (2016).
50 Singh, A. & Settleman, J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29, 4741-4751, doi:10.1038/onc.2010.215 (2010).
51 Lei, Q. Y. et al. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol 28, 2426-2436, doi:10.1128/mcb.01874-07 (2008).
52 Cordenonsi, M. et al. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 147, 759-772, doi:10.1016/j.cell.2011.09.048 (2011).
53 Li, Z. et al. The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer. Mol Oncol 9, 1091-1105, doi:10.1016/j.molonc.2015.01.007 (2015).
54 Tang, Y. & Weiss, S. J. Snail/Slug-YAP/TAZ complexes cooperatively regulate mesenchymal stem cell function and bone formation. Cell Cycle 16, 399-405, doi:10.1080/15384101.2017.1280643 (2017).
55 Lea, M. A., Kim, H. & des, B. C. Effects of Biguanides on Growth and Glycolysis of Bladder and Colon Cancer Cells. Anticancer Res 38, 5003-5011, doi:10.21873/anticanres.12819 (2018).
56 Xian, S., Shang, D., Kong, G. & Tian, Y. FOXJ1 promotes bladder cancer cell growth and regulates Warburg effect. Biochem Biophys Res Commun 495, 988-994, doi:10.1016/j.bbrc.2017.11.063 (2018).
57 Chen, J., Cao, L., Li, Z. & Li, Y. SIRT1 promotes GLUT1 expression and bladder cancer progression via regulation of glucose uptake. Hum Cell 32, 193-201, doi:10.1007/s13577-019-00237-5 (2019).
58 Liberti, M. V. & Locasale, J. W. The Warburg Effect: How Does it Benefit Cancer Cells? Trends Biochem Sci 41, 211-218, doi:10.1016/j.tibs.2015.12.001 (2016).
59 Yoshino, H. et al. Aberrant expression of microRNAs in bladder cancer. Nat Rev Urol 10, 396-404, doi:10.1038/nrurol.2013.113 (2013).